IMRN (IMRN) Stock Price & Analysis
IMRN (IMRN) rose 62.16% to USD 1.8 as of September 8, 2026 at 10:47 UTC, according to Nexqual real-time market data.
IMRN last closed at USD 1.8; the session ranged USD 1.54–1.99 on volume of 123,135,090 shares. Market capitalization is —, with a 52-week range of USD 0.68–2.39 (NCM). Source: Nexqual, September 8, 2026 at 10:47 UTC.
Key Statistics (as of September 8, 2026 at 10:47 UTC)
| Price | USD 1.8 |
|---|---|
| Change | ▲ 62.16% (up) |
| Previous Close | USD 1.8 |
| Open | USD 1.8 |
| Day Range | USD 1.54 – 1.99 |
| 52-Week Range | USD 0.68 – 2.39 |
| Volume | 123,135,090 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (IMRN)
Nexqual's technical model rates IMRN "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 10:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 77.95 (overbought) |
| vs SMA50 | Above (USD 1.15) |
| MACD | 0.05 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATHE | Alterity Therapeutics Limited | USD 4.54 | ▲ 0.44% |
| EDSA | Edesa Biotech, Inc. | USD 4.73 | ▼ 0.63% |
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.33 | ▲ 2.71% |
| WAFU | Wah Fu Education Group Limited | USD 1.36 | ▼ 2.86% |
| IMMP | Immutep Limited | USD 0.36 | ▼ 3.97% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:47 UTC. This page is informational and not investment advice.